Baker McKenzie (Gaikokuho Joint Enterprise) has a richly resourced corporate and M&A department, acting for a substantial proportion of technology and chemicals companies. The department draws on its global offices to provide comprehensive advice on cross-border matters, spanning corporate acquisitions, joint ventures and business restructurings. The team is led by Jiro Toyokawa, who is deeply experienced in both public and private M&A, with particular expertise in handling major outbound transactions. Co-managing partner of the Tokyo office, Akifusa Takada, focuses on domestic transactions, regularly instructing Japanese companies across the pharmaceutical, food and consumer goods industries. Kiyoshi Endo has a broad practice, advising on both inbound and outbound M&A. Within the team, Tetsuo Tsujimoto and Yutaka Kimura are other highlighted members.
Legal 500 Editorial commentary
Phone
+ 81 3 6271 9900
Email
Profile

Profile

Work Department
Transactional - Mergers & Acquisitions
Position

Partner

Career

Jiro's practice is focused on M&A (especially inbound and outbound cross-border M&A) and joint ventures. He is also well-versed in M&A-related matters ― including employment and merger control issues ― and has experience advising on a variety of commercial transactions involving license agreements, venture capital funds, stock options, securitizations and litigation stemming from M&As and corporate reorganizations.

Jiro routinely handles matters related to corporate law, securities law (including stock exchange regulations), employment law, antitrust law and foreign exchange law. He has assisted many clients seeking to expand overseas and has advised numerous corporations in the insurance, IT and industrial sectors. Jiro has also advised Japanese companies on their outbound investments in the US, the UK, Germany, Hong Kong, Indonesia, Malaysia, Turkey, Australia, Poland, Singapore and Thailand, among others.

Languages
English; Japanese

Content supplied by Baker McKenzie (Gaikokuho Joint Enterprise)

Testimonials

Collated independently by Legal 500 research team.

  • 'Great team with a broad international experience and good understanding of the business needs behind the transaction. Diligent, efficient and very responsive.' 'Yutaka Kimura and Masahiro Inaba are professional, have broad international experience, and excellent proficiency in English, with a broad and business-oriented approach.' 'As for Mr. Yutaka Kimura, whom I worked with for a certain project, I can say he is excellent because of his full commitment to the project, proactive and diligent support, and energetic and hard-working attitude.' 'Even in the case of a cross-border, we can receive one-stop legal services in many cases. The team always explains in detail, even if we ask an abstract question.' 'Mr. Masahiro Inaba has extensive experience. We can receive advice backed by their experience.' 'The whole team is diligent. Smooth collaboration with local counsel. Every lawyer has a certain value.' 'Jon R. Ornolfsson has long experience in the energy sector in Southeast Asia, with an excellent understanding of Japanese company culture.' 'Safari Watanabe is a brilliant lawyer and a fabulous person who takes the time and effort to learn her client’s business.'

Key clients

  • Rivulets Investments Seiko Epson Corporation Sumitomo Mitsui Finance and Leasing Company, Limited UBE Corporation Central Tank Terminal Co., Ltd. Daiwa House Heiwa Corporation J-STAR Co., Ltd., Potentia Capital Meiji Yasuda Life Insurance Company Nikkiso Co., Ltd. Sumitomo Chemical Company, Limited YAGEO Corporation

Work highlights

Advised Seiko Epson Corporation on its acquisition of Fiery, LLC, an industry-leading provider of printing-related software. The acquisition is valued at approximately USD 591 million.
Advised UBE Corporation, a leading Japanese chemical company based in Tokyo, on its acquisition of LANXESS' Urethane Systems business (LANXESS Deutschland GmbH, head office: Germany) for a purchase price of approximately EUR 460 million.
Advised Nikkiso Co., Ltd. on the sale of its continuous renal replacement therapy (CRRT) business to TYHC International PTE. LTD., an investment entity affiliated with Ningbo Tianyi Medical Appliance Co., Ltd., a leading company in blood purification consumables in China.